SJ Berwin advises BioAmber on its dual listing
SJ Berwin advised BioAmber, a sustainable chemicals company on its Initial Public Offering on the NYSE and the simultaneous listing of its common stock on the professional segment of Euronext Paris. BioAmber is the first US company to use Euronext’s Fast Path process in the context of its Initial Public Offering on its original market. The offering raised a total of US$80 million, valuing the company at US$180 million.